Around US$ 1207.3 million is projected to be the value of global sales of gastroesophageal reflux disease (GERD) device in 2024. By 2034, the gastroesophageal reflux disease (GERD) device market is anticipated to advance at a 3.6% CAGR and surpass a valuation of US$ 1719.5 million. The increasing prevalence of GERD and the development of less invasive treatment options are projected to contribute to the gastroesophageal reflux disease device market's steady rise.
Technological advancements such as endoscopic therapy and magnetic sphincter augmentation devices are becoming a growing trend since they provide efficient substitutes for conventional surgical and pharmaceutical methods. The gastroesophageal reflux disease (GERD) device market is expanding due to patients and healthcare professionals becoming conscious of the advantages of these devices, which include quicker recovery times and enhanced quality of life.
| Attributes | Details |
|---|---|
| Market Value for 2024 | US$ 1207.3 million |
| Market Value for 2034 | US$ 1719.5 million |
| Market CAGR from 2024 to 2034 | 3.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Attributes | Details |
|---|---|
| Market Value for 2019 | US$ 1001 million |
| Market Value for 2023 | US$ 1213.4 million |
| Market CAGR from 2019 to 2023 | 3.9% |
Principal Consultant
The segmented study of the gastroesophageal reflux disease (GERD) device market is detailed in the part below. Extensive research demonstrates that diagnostic procedures are at the forefront of procedural innovations, with esophagoscopes and gastroscopes commanding the product segment.
This comprehensive analysis sheds light on the constantly shifting landscape of GERD management, identifying major trends and in the gastroesophageal reflux disease device market.
| Segment | Esophagoscopes and Gastroscopes |
|---|---|
| Share (2024) | 90% |
| Segment | Diagnostic Procedures |
|---|---|
| Share (2024) | 68% |
The GERD device market can be observed in the subsequent tables, which focus on the leading regions in North America, Europe, and Asia Pacific. A comprehensive evaluation demonstrates that Asia Pacific has enormous market opportunities for gastroesophageal reflux disease device.
Opportunities in the Asia Pacific Gastroesophageal Reflux Disease (GERD) Device Industry
| Countries | CAGR (2024 to 2034) |
|---|---|
| India | 5.2% |
| Thailand | 5.0% |
| Malaysia | 4.6% |
| Indonesia | 3.4% |
Insights into Sales Performance of Gastroesophageal Reflux Disease (GERD) Device in North America
| Countries | CAGR (2024 to 2034) |
|---|---|
| United States | 2.6% |
| Canada | 2.9% |
Opportunities for Gastroesophageal Reflux Disease (GERD) Device Market in Europe
| Countries | CAGR (2024 to 2034) |
|---|---|
| Germany | 1.9% |
| United Kingdom | 1.6% |
| France | 2.3% |
| Italy | 2.0% |
| Spain | 2.9% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Several prominent gastroesophageal reflux disease device vendors are vying for market share in the highly competitive atmosphere of the industry.
Notable gastroesophageal reflux disease device manufacturers influencing the direction of the business are Olympus Corporation, Pentax Medical, KARL STORZ SE & Co KG, Medtronic Plc, Fujifilm Holdings Corporation, EndoGastric Solutions, Medigus Ltd., and Diversatek Inc. By addressing the difficulties associated with managing GERD, these gastroesophageal reflux disease device businesses offer a variety of technological expertise, creating a competitive atmosphere centered on enhancing patient outcomes and expanding available treatment options.
Olympus Corporation, Pentax Medical, KARL STORZ SE, and Co KG are improving GERD device technology. This gastroesophageal reflux disease (GERD) device providers are known for their dedication to quality and innovation. Medtronic Plc uses its broad healthcare portfolio to provide comprehensive solutions for managing GERD, while Fujifilm Holdings Corporation contributes its imaging expertise to improve diagnostic capabilities.
By providing specialized tools and methods that address particular patient demands and broaden the range of available treatments, EndoGastric Solutions, Medigus Ltd., and Diversatek Inc. make contributions.
Continuous innovation and development in GERD management tactics are expected as these major gastroesophageal reflux disease device vendors cooperate and compete. These gastroesophageal reflux disease device suppliers are essential in influencing the direction of GERD therapy and enhancing the lives of those impacted by the disease by emphasizing patient-centric solutions and technical innovations.
Notable Strides
| Company | Details |
|---|---|
| Wockhardt Ltd. | Wockhardt Ltd. acquired its authorized generic versions of several over-the-counter medications from Glenmark Pharmaceuticals Ltd. in June 2022. The approved abbreviated new drug applications for famotidine tablets, which are used to treat and prevent stomach and intestinal ulcers, as well as treatment drug Lansoprazole delayed-release capsules USP, 15 mg, are among the medications included in the acquisition by the company's fully owned subsidiary Glenmark Pharmaceuticals Inc, USA. |
| Zydus Lifesciences | The FDA approved Zydus Lifesciences' 20 mg and 40 mg formulations of metronidazole tablets for sale in June 2022. As a histamine H2 receptor blocker, famotidine lowers stomach acid production. The medication is intended to treat and prevent acid reflux disease (GERD) as well as other related symptoms. |
| Peptest | Peptest, a non-invasive radiofrequency device designed by RD Biomed for the diagnosis of reflux devices, was approved by China. This device detects pepsin in saliva samples and helps with the overall treatment of reflux-related devices. |
| EsophyX Z | An improved and more recent version of the EsophyX device is the EsophyX Z gastroesophageal reflux disease device, used to perform transoral incisionless fundoplication. |
The GERD device market to secure a valuation US$ 1207.3 million in 2024.
The GERD device market is estimated to attain US$ 1719.5 million by 2034.
Through 2034, the GERD device market is anticipated to evolve at a 3.6% CAGR.
From 2019 to 2023, the gastroesophageal reflux disease (GERD) device market registered a 3.9% CAGR.
The esophagoscopes and gastroscopes sector is set to achieve a market share of 90% in 2024.
A 68% market share is expected for the diagnostic procedures sector in 2024.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Manufacturer
3.5.1.2. Mid-Level Participants (Traders)
3.5.1.3. Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Distributors
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034
5.3.1. Diagnostic Devices
5.3.2. Manometry Systems
5.3.3. PH Monitoring Systems
5.3.4. Esophagoscopes and Gastroscopes
5.3.5. Treatment Devices
5.3.6. Ultrasonic Surgical Endostaplers
5.3.7. Fundoplication Devices
5.3.8. Sphincter Augmentation Devices
5.3.9. Radiofrequency Ablation Devices
5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Procedure
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Procedure, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Procedure, 2024 to 2034
6.3.1. Diagnostic Procedures
6.3.2. Fundoplication Procedures
6.3.3. Radiofrequency Thermal Ablation
6.3.4. Magnetic Sphincter Augmentation
6.4. Y-o-Y Growth Trend Analysis By Procedure, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Procedure, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2024 to 2034
7.3.1. Hospitals
7.3.2. Diagnostic Centers
7.3.3. Ambulatory Surgical Centers
7.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Procedure
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Procedure
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Procedure
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Procedure
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product
11.2.3. By Procedure
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Procedure
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product
12.2.3. By Procedure
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Procedure
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product
13.2.3. By Procedure
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Procedure
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product
14.2.3. By Procedure
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Procedure
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Procedure
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Procedure
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2023
16.1.2.1. By Product
16.1.2.2. By Procedure
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2023
16.2.2.1. By Product
16.2.2.2. By Procedure
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2023
16.3.2.1. By Product
16.3.2.2. By Procedure
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2023
16.4.2.1. By Product
16.4.2.2. By Procedure
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2023
16.5.2.1. By Product
16.5.2.2. By Procedure
16.5.2.3. By End User
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2023
16.6.2.1. By Product
16.6.2.2. By Procedure
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2023
16.7.2.1. By Product
16.7.2.2. By Procedure
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2023
16.8.2.1. By Product
16.8.2.2. By Procedure
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2023
16.9.2.1. By Product
16.9.2.2. By Procedure
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2023
16.10.2.1. By Product
16.10.2.2. By Procedure
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2023
16.11.2.1. By Product
16.11.2.2. By Procedure
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2023
16.12.2.1. By Product
16.12.2.2. By Procedure
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2023
16.13.2.1. By Product
16.13.2.2. By Procedure
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2023
16.14.2.1. By Product
16.14.2.2. By Procedure
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2023
16.15.2.1. By Product
16.15.2.2. By Procedure
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2023
16.16.2.1. By Product
16.16.2.2. By Procedure
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2023
16.17.2.1. By Product
16.17.2.2. By Procedure
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2023
16.18.2.1. By Product
16.18.2.2. By Procedure
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2023
16.19.2.1. By Product
16.19.2.2. By Procedure
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2023
16.20.2.1. By Product
16.20.2.2. By Procedure
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2023
16.21.2.1. By Product
16.21.2.2. By Procedure
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2023
16.22.2.1. By Product
16.22.2.2. By Procedure
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2023
16.23.2.1. By Product
16.23.2.2. By Procedure
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Procedure
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Olympus Corporation
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Pentax Medical
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. KARL STORZ SE & Co KG.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Medtronic Plc
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Fujifilm Holdings Corporation
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. EndoGastric Solutions
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Medigus Ltd.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Diversatek Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. LABORIE
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Mederi Therapeutics Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Healthcare
March 2023
REP-GB-16787
301 pages
Explore Healthcare Insights
View Reports
Gastroesophageal Reflux Disease (GERD) Device Market
